PureCycle Technologies (PCT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved significant operational and commercial progress, including the launch of the Denver, PA sorting facility and commercialization of the Ironton facility, with first major purchase order from Drake Extrusion and the launch of the Run It Back product line with Churchill Container.
Expanded customer trials across multiple segments, with over 29 trials underway and more than 20 at industrial scale, supported by a growing commercial team.
Amended license agreement with Procter & Gamble, securing North American exclusivity and expanding global collaboration, with industrial trials for five applications.
Achieved stable production at Ironton, reaching 12,500 lbs/hour (88% of nameplate) and nearly 70% onstream time in December.
Raised $33 million in February 2025 from institutional investors, supporting liquidity and growth initiatives.
Financial highlights
Ended Q4 with just under $16 million in unrestricted cash and $25.8 million in restricted cash; total cash at year-end was $41.5 million.
Raised $33 million in February 2025 from institutional investors via private placement.
Q4 cash expenses totaled $68 million, including $36 million for equipment; adjusted cash expense was $27 million.
Major cash uses included $9.3 million for Ironton operations, $41.4 million for growth projects, and $5 million for SOPA Revenue Bond interest.
Holds $118 million in revenue bonds, expected to be sold in 2025 to further enhance liquidity.
Outlook and guidance
Confident in ability to sell out Ironton capacity in the near term, driven by strong customer demand and successful trials.
Expecting third-party PCR certification for 7.2 million lbs of inventory by end of Q1, unlocking additional sales.
Final qualification for initial applications with P&G brands expected in Q2 2025, with first production anticipated in Q2 or Q3 2025.
Augusta project remains on track, with site preparation underway and improved financing outlook due to Ironton’s success.
Global expansion plans progressing, with long-lead equipment purchased for two 130 million lbs lines and strong interest in Europe and Asia.
Latest events from PureCycle Technologies
- Record production, new funding, and strong trials set stage for growth despite ongoing losses.PCT
Q3 20249 Jul 2026 - First $1.6M revenue, 90% uptime, BOPP breakthroughs, and $59M+ capital raised in Q1 2025.PCT
Q1 20258 Jul 2026 - Record production and revenue growth, with robust liquidity and strong commercial momentum.PCT
Q1 20267 May 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.PCT
Proxy filing27 Mar 2026 - Annual meeting covers director elections, auditor ratification, executive pay, global growth, and ESG milestones.PCT
Proxy filing27 Mar 2026 - Proposal seeks to lower the warrant Redemption Trigger Price and extend expiration to 2027.PCT
Proxy filing26 Mar 2026 - Gen 2 technology and regulatory shifts position the company for rapid growth and global expansion.PCT
The 38th Annual Roth Conference23 Mar 2026 - Proposal seeks to lower warrant trigger price and extend expiration, pending majority consent.PCT
Proxy Filing16 Mar 2026 - Record Q4 production and $2.7M revenue growth set the stage for global expansion in 2026.PCT
Q4 202527 Feb 2026